Skip to content

13F-HR filed by Nan Fung Group Holdings Ltd

Nan Fung Group Holdings Ltd filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 55 holding rows worth $337,973,000.

Accession
0001012975-22-000078
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A combination report, 55 entries on the cover page, a total value of $337,973,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $337,973,000 with VALUE read as thousands by filing date, 13F file number 028-21371. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NEW FRONTIER HEALTH CORPG6461G106ORD SHS8,350,000$95,691,000thousands by filing date
ILLUMINA INC452327109COM129,647$49,323,000thousands by filing date
HARMONY BIOSCIENCES HLDGS IN413197104COM768,708$32,778,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM234,811$30,760,000thousands by filing date
SOMALOGIC INC83444K105COM1,696,558$19,748,000thousands by filing date
EXSCIENTIA PLC30223G102ADS770,200$15,219,000thousands by filing date
EARGO INC270087109COM2,886,724$14,722,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM210,563$8,816,000thousands by filing date
RANI THERAPEUTICS HLDGS INC753018100CMN493,584$8,070,000thousands by filing date
SEAGEN INC81181C104COM45,340$7,010,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock197,880$6,182,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM1,166,952$5,718,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM54,903$4,375,000thousands by filing date
NEW FRONTIER HEALTH CORPG6461G114*W EXP 11/30/2021,580,000$4,266,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock171,760$3,514,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR11,205$3,036,000thousands by filing date
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK613,223$2,815,000thousands by filing date
INCYTE CORP COM45337C102Stock34,510$2,533,000thousands by filing date
INVITAE CORP46185L103COM157,862$2,411,000thousands by filing date
OTONOMY INC68906L105COM851,000$1,770,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR12,600$1,695,000thousands by filing date
TRAVERE THERAPEUTICS INC89422G107COM48,500$1,505,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock17,464$1,359,000thousands by filing date
EXELIXIS INC COM30161Q104Stock64,200$1,174,000thousands by filing date
SIERRA ONCOLOGY INC82640U404CMN52,979$1,152,000thousands by filing date
KODIAK SCIENCES INC50015M109COM13,440$1,139,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM78,720$1,041,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK41,950$902,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM35,035$818,000thousands by filing date
BLUEBIRD BIO INC09609G100COM78,350$783,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM7,460$659,000thousands by filing date
SATSUMA PHARMACEUTICALS INC80405P107COM142,900$643,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR370,950$594,000thousands by filing date
RUBIUS THERAPEUTICS INC78116T103COM56,768$550,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM19,700$499,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS9,340$435,000thousands by filing date
Surrozen, Inc.86889P109COM65,070$419,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR1,130$396,000thousands by filing date
KYMERA THERAPEUTICS INC501575104COM4,960$315,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM25,500$279,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM1,810$266,000thousands by filing date
PRELUDE THERAPEUTICS INC74065P101CMN20,350$253,000thousands by filing date
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS22,200$250,000thousands by filing date
Tscan Therapeutics Inc89854M101COM48,600$219,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A8,265$218,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock15,545$215,000thousands by filing date
AMRYT PHARMA LTD - SPNR ADR03217L106COMMON EQUITY19,150$207,000thousands by filing date
Day One Biopharmaceuticals Inc23954D109Common Stock11,445$193,000thousands by filing date
ABCELLERA BIOLOGICS INC COM00288U106Stock13,180$188,000thousands by filing date
ATYR PHARMA INC002120202COM NEW23,500$176,000thousands by filing date
SYNLOGIC INC87166L100COM68,634$166,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock11,650$163,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock11,629$138,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW11,050$113,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW27,925$94,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-22-000078this filing2022-02-14acceptance time not in the bulk data set